Douglas G. McNeel is currently a Tenured Associate Professor in the Department of Medicine, Section of Hematology/Oncology, at the University of Wisconsin-Madison, Madison, Wis, USA. McNeel received his Ph.D. degree in 1992 and M.D. degree in 1994 from the University of Chicago, Chicago, Ill, USA. He then completed internal medicine residency and medical oncology fellowship training at the University of Washington and Fred Hutchinson Cancer Research Center in Seattle, Wash, USA. He has been on the Faculty at the University of Wisconsin since 2001. He is a genitourinary oncologist with a clinical research focus on prostate cancer, and serves as Coleader of the Experimental Therapeutics program of the University of Wisconsin Carbone Cancer Center. McNeel’s laboratory research program is focused on prostate cancer immunology with the goal of developing antitumor vaccines as treatments for prostate cancer. Current efforts seek to identify immunologically recognized proteins of the prostate, characterize these as tumor antigens, evaluate antitumor vaccines targeting these antigens in appropriate rodent models, and translate these findings to early phase human clinical trials.
Biography Updated on 24 March 2011